+1 (704) 266-3234

Global Lysosomal Storage Diseases Market Size, Status And Forecast 2019-2025

Published on: Jan 2019 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 97

Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.

According to the report, one driver in the market is unmet medical needs.

In 2018, the global Lysosomal Storage Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.



This report focuses on the global Lysosomal Storage Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lysosomal Storage Diseases development in United States, Europe and China.



The key players covered in this study

Actelion Pharmaceuticals

BioMarin

Genzyme

Shire

Alexion Pharmaceuticals

Amicus Therapeutics

Chiesi Farmaceutici

Greenovation Biotech And FGK Clinical Research

Horizon Pharma

Leadiant Biosciences

Mylan



Market segment by Type, the product can be split into

Enzyme Replacement Therapy

Substrate Reduction Therapy

Cystine Depleting Agents



Market segment by Application, split into

Hospitals

Ambulatory Surgical Centers



Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America



The study objectives of this report are:

To analyze global Lysosomal Storage Diseases status, future forecast, growth opportunity, key market and key players.

To present the Lysosomal Storage Diseases development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.



In this study, the years considered to estimate the market size of Lysosomal Storage Diseases are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents



1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Lysosomal Storage Diseases Market Size Growth Rate by Type (2014-2025)

1.4.2 Enzyme Replacement Therapy

1.4.3 Substrate Reduction Therapy

1.4.4 Cystine Depleting Agents

1.5 Market by Application

1.5.1 Global Lysosomal Storage Diseases Market Share by Application (2014-2025)

1.5.2 Hospitals

1.5.3 Ambulatory Surgical Centers

1.6 Study Objectives

1.7 Years Considered



2 Global Growth Trends

2.1 Lysosomal Storage Diseases Market Size

2.2 Lysosomal Storage Diseases Growth Trends by Regions

2.2.1 Lysosomal Storage Diseases Market Size by Regions (2014-2025)

2.2.2 Lysosomal Storage Diseases Market Share by Regions (2014-2019)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities



3 Market Share by Key Players

3.1 Lysosomal Storage Diseases Market Size by Manufacturers

3.1.1 Global Lysosomal Storage Diseases Revenue by Manufacturers (2014-2018)

3.1.2 Global Lysosomal Storage Diseases Revenue Market Share by Manufacturers (2014-2018)

3.1.3 Global Lysosomal Storage Diseases Market Concentration Ratio (CR5 and HHI)

3.2 Lysosomal Storage Diseases Key Players Head office and Area Served

3.3 Key Players Lysosomal Storage Diseases Product/Solution/Service

3.4 Date of Enter into Lysosomal Storage Diseases Market

3.5 Mergers & Acquisitions, Expansion Plans



4 Breakdown Data by Type and Application

4.1 Global Lysosomal Storage Diseases Market Size by Type (2014-2019)

4.2 Global Lysosomal Storage Diseases Market Size by Application (2014-2019)



5 United States

5.1 United States Lysosomal Storage Diseases Market Size (2014-2019)

5.2 Lysosomal Storage Diseases Key Players in United States

5.3 United States Lysosomal Storage Diseases Market Size by Type

5.4 United States Lysosomal Storage Diseases Market Size by Application



6 Europe

6.1 Europe Lysosomal Storage Diseases Market Size (2014-2019)

6.2 Lysosomal Storage Diseases Key Players in Europe

6.3 Europe Lysosomal Storage Diseases Market Size by Type

6.4 Europe Lysosomal Storage Diseases Market Size by Application



7 China

7.1 China Lysosomal Storage Diseases Market Size (2014-2019)

7.2 Lysosomal Storage Diseases Key Players in China

7.3 China Lysosomal Storage Diseases Market Size by Type

7.4 China Lysosomal Storage Diseases Market Size by Application



8 Japan

8.1 Japan Lysosomal Storage Diseases Market Size (2014-2019)

8.2 Lysosomal Storage Diseases Key Players in Japan

8.3 Japan Lysosomal Storage Diseases Market Size by Type

8.4 Japan Lysosomal Storage Diseases Market Size by Application



9 Southeast Asia

9.1 Southeast Asia Lysosomal Storage Diseases Market Size (2014-2019)

9.2 Lysosomal Storage Diseases Key Players in Southeast Asia

9.3 Southeast Asia Lysosomal Storage Diseases Market Size by Type

9.4 Southeast Asia Lysosomal Storage Diseases Market Size by Application



10 India

10.1 India Lysosomal Storage Diseases Market Size (2014-2019)

10.2 Lysosomal Storage Diseases Key Players in India

10.3 India Lysosomal Storage Diseases Market Size by Type

10.4 India Lysosomal Storage Diseases Market Size by Application



11 Central & South America

11.1 Central & South America Lysosomal Storage Diseases Market Size (2014-2019)

11.2 Lysosomal Storage Diseases Key Players in Central & South America

11.3 Central & South America Lysosomal Storage Diseases Market Size by Type

11.4 Central & South America Lysosomal Storage Diseases Market Size by Application



12 International Players Profiles

12.1 Actelion Pharmaceuticals

12.1.1 Actelion Pharmaceuticals Company Details

12.1.2 Company Description and Business Overview

12.1.3 Lysosomal Storage Diseases Introduction

12.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2014-2019)

12.1.5 Actelion Pharmaceuticals Recent Development

12.2 BioMarin

12.2.1 BioMarin Company Details

12.2.2 Company Description and Business Overview

12.2.3 Lysosomal Storage Diseases Introduction

12.2.4 BioMarin Revenue in Lysosomal Storage Diseases Business (2014-2019)

12.2.5 BioMarin Recent Development

12.3 Genzyme

12.3.1 Genzyme Company Details

12.3.2 Company Description and Business Overview

12.3.3 Lysosomal Storage Diseases Introduction

12.3.4 Genzyme Revenue in Lysosomal Storage Diseases Business (2014-2019)

12.3.5 Genzyme Recent Development

12.4 Shire

12.4.1 Shire Company Details

12.4.2 Company Description and Business Overview

12.4.3 Lysosomal Storage Diseases Introduction

12.4.4 Shire Revenue in Lysosomal Storage Diseases Business (2014-2019)

12.4.5 Shire Recent Development

12.5 Alexion Pharmaceuticals

12.5.1 Alexion Pharmaceuticals Company Details

12.5.2 Company Description and Business Overview

12.5.3 Lysosomal Storage Diseases Introduction

12.5.4 Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2014-2019)

12.5.5 Alexion Pharmaceuticals Recent Development

12.6 Amicus Therapeutics

12.6.1 Amicus Therapeutics Company Details

12.6.2 Company Description and Business Overview

12.6.3 Lysosomal Storage Diseases Introduction

12.6.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2014-2019)

12.6.5 Amicus Therapeutics Recent Development

12.7 Chiesi Farmaceutici

12.7.1 Chiesi Farmaceutici Company Details

12.7.2 Company Description and Business Overview

12.7.3 Lysosomal Storage Diseases Introduction

12.7.4 Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2014-2019)

12.7.5 Chiesi Farmaceutici Recent Development

12.8 Greenovation Biotech And FGK Clinical Research

12.8.1 Greenovation Biotech And FGK Clinical Research Company Details

12.8.2 Company Description and Business Overview

12.8.3 Lysosomal Storage Diseases Introduction

12.8.4 Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2014-2019)

12.8.5 Greenovation Biotech And FGK Clinical Research Recent Development

12.9 Horizon Pharma

12.9.1 Horizon Pharma Company Details

12.9.2 Company Description and Business Overview

12.9.3 Lysosomal Storage Diseases Introduction

12.9.4 Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2014-2019)

12.9.5 Horizon Pharma Recent Development

12.10 Leadiant Biosciences

12.10.1 Leadiant Biosciences Company Details

12.10.2 Company Description and Business Overview

12.10.3 Lysosomal Storage Diseases Introduction

12.10.4 Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2014-2019)

12.10.5 Leadiant Biosciences Recent Development

12.11 Mylan



13 Market Forecast 2019-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2019-2025)

13.10 Market Size Forecast by Application (2019-2025)



14 Analyst's Viewpoints/Conclusions



15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures



Table Lysosomal Storage Diseases Key Market Segments

Table Key Players Lysosomal Storage Diseases Covered

Table Global Lysosomal Storage Diseases Market Size Growth Rate by Type 2014-2025 (Million US$)

Figure Global Lysosomal Storage Diseases Market Size Market Share by Type 2014-2025

Figure Enzyme Replacement Therapy Figures

Table Key Players of Enzyme Replacement Therapy

Figure Substrate Reduction Therapy Figures

Table Key Players of Substrate Reduction Therapy

Figure Cystine Depleting Agents Figures

Table Key Players of Cystine Depleting Agents

Table Global Lysosomal Storage Diseases Market Size Growth by Application 2014-2025 (Million US$)

Figure Hospitals Case Studies

Figure Ambulatory Surgical Centers Case Studies

Figure Lysosomal Storage Diseases Report Years Considered

Table Global Lysosomal Storage Diseases Market Size 2014-2025 (Million US$)

Figure Global Lysosomal Storage Diseases Market Size and Growth Rate 2014-2025 (Million US$)

Table Global Lysosomal Storage Diseases Market Size by Regions 2014-2025 (Million US$)

Table Global Lysosomal Storage Diseases Market Size by Regions 2014-2019 (Million US$)

Table Global Lysosomal Storage Diseases Market Share by Regions 2014-2019

Figure Global Lysosomal Storage Diseases Market Share by Regions 2014-2019

Figure Global Lysosomal Storage Diseases Market Share by Regions 2019

Table Market Top Trends

Table Global Lysosomal Storage Diseases Revenue by Manufacturers (2014-2019) (Million US$)

Table Global Lysosomal Storage Diseases Market Share by Manufacturers (2014-2019)

Figure Global Lysosomal Storage Diseases Market Share by Manufacturers in 2018

Table Global Lysosomal Storage Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Players Head office and Area Served

Table Key Players Lysosomal Storage Diseases Product/Solution/Service

Table Date of Enter into Lysosomal Storage Diseases Market

Table Mergers & Acquisitions, Expansion Plans

Table Global Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)

Table Global Lysosomal Storage Diseases Market Size Share by Type (2014-2019)

Figure Global Lysosomal Storage Diseases Market Size Market Share by Type (2014-2019)

Table Global Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)

Table Global Lysosomal Storage Diseases Market Size Share by Application (2014-2019)

Figure Global Lysosomal Storage Diseases Market Size Market Share by Application (2014-2019)

Figure Global Lysosomal Storage Diseases Revenue Market Share by Application in 2018

Figure United States Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)

Table United States Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)

Table United States Key Players Lysosomal Storage Diseases Market Share (2018-2019)

Table United States Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)

Table United States Lysosomal Storage Diseases Market Share by Type (2014-2019)

Table United States Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)

Table United States Lysosomal Storage Diseases Market Share by Application (2014-2019)

Figure Europe Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)

Table Europe Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)

Table Europe Key Players Lysosomal Storage Diseases Market Share (2018-2019)

Table Europe Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)

Table Europe Lysosomal Storage Diseases Market Share by Type (2014-2019)

Table Europe Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)

Table Europe Lysosomal Storage Diseases Market Share by Application (2014-2019)

Figure China Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)

Table China Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)

Table China Key Players Lysosomal Storage Diseases Market Share (2018-2019)

Table China Lysosomal Storage Diseases Market Size by Type (2014-20189) (Million US$)

Table China Lysosomal Storage Diseases Market Share by Type (2014-2019)

Table China Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)

Table China Lysosomal Storage Diseases Market Share by Application (2014-2019)

Figure Japan Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)

Table Japan Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)

Table Japan Key Players Lysosomal Storage Diseases Market Share (2018-2019)

Table Japan Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)

Table Japan Lysosomal Storage Diseases Market Share by Type (2014-2019)

Table Japan Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)

Table Japan Lysosomal Storage Diseases Market Share by Application (2014-2019)

Figure Southeast Asia Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)

Table Southeast Asia Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)

Table Southeast Asia Key Players Lysosomal Storage Diseases Market Share (2018-2019)

Table Southeast Asia Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)

Table Southeast Asia Lysosomal Storage Diseases Market Share by Type (2014-2019)

Table Southeast Asia Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)

Table Southeast Asia Lysosomal Storage Diseases Market Share by Application (2014-2019)

Figure India Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)

Table India Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)

Table India Key Players Lysosomal Storage Diseases Market Share (2018-2019)

Table India Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)

Table India Lysosomal Storage Diseases Market Share by Type (2014-2019)

Table India Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)

Table India Lysosomal Storage Diseases Market Share by Application (2014-2019)

Figure Central & South America Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)

Table Central & South America Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)

Table Central & South America Key Players Lysosomal Storage Diseases Market Share (2018-2019)

Table Central & South America Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)

Table Central & South America Lysosomal Storage Diseases Market Share by Type (2014-2019)

Table Central & South America Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)

Table Central & South America Lysosomal Storage Diseases Market Share by Application (2014-2019)

Table Actelion Pharmaceuticals Company Details

Table Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2014-2019) (Million US$)

Figure Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)

Table Actelion Pharmaceuticals Recent Development

Table BioMarin Company Details

Table BioMarin Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)

Figure BioMarin Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)

Table BioMarin Recent Development

Table Genzyme Company Details

Table Genzyme Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)

Figure Genzyme Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)

Table Genzyme Recent Development

Table Shire Company Details

Table Shire Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)

Figure Shire Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)

Table Shire Recent Development

Table Alexion Pharmaceuticals Company Details

Table Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)

Figure Alexion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)

Table Alexion Pharmaceuticals Recent Development

Table Amicus Therapeutics Company Details

Table Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)

Figure Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)

Table Amicus Therapeutics Recent Development

Table Chiesi Farmaceutici Company Details

Table Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)

Figure Chiesi Farmaceutici Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)

Table Chiesi Farmaceutici Recent Development

Table Greenovation Biotech And FGK Clinical Research Company Details

Table Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)

Figure Greenovation Biotech And FGK Clinical Research Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)

Table Greenovation Biotech And FGK Clinical Research Recent Development

Table Horizon Pharma Company Details

Table Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)

Figure Horizon Pharma Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)

Table Horizon Pharma Recent Development

Table Leadiant Biosciences Company Details

Table Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)

Figure Leadiant Biosciences Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)

Table Leadiant Biosciences Recent Development

Table Mylan Company Details

Table Global Lysosomal Storage Diseases Market Size by Regions (Million US$) 2019-2025

Figure Global Lysosomal Storage Diseases Market Size Share by Regions (2019-2025)

Figure Global Lysosomal Storage Diseases Market Size Share by Regions in 2025

Figure United States Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)

Figure Europe Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)

Figure China Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)

Figure Japan Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)

Figure Southeast Asia Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)

Figure India Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)

Figure Central & South America Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)

Table Global Lysosomal Storage Diseases Market Size by Product (2019-2025) (Million US$)

Figure Global Lysosomal Storage Diseases Market Size by Product (2019-2025)

Figure Global Lysosomal Storage Diseases Market Size by Product in 2025

Table Global Lysosomal Storage Diseases Market Size by Application (2019-2025) (Million US$)

Figure Global Lysosomal Storage Diseases Market Size by Application (2019-2025)

Figure Global Lysosomal Storage Diseases Market Size by Application in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.